Within the framework of the Research Colloquium, a regular exchange on current research questions takes place at the Department etit. Renowned external scientists are invited to give keynote speeches.

Research Colloquium on Medical Technology

The Department of etit opens the academic year in winter semester 2022/23 with a research colloquium on medical technology. It will take place in presence. Participation via Zoom is also possible.

We were able to win two speakers for the keynote speeches:

  • Prof. Dr.-Ing. habil. Hagen Malberg, TU Dresden
  • Prof. Dr. Boris Mizaikoff, University of Ulm and Hahn-Schickard Institute for Microanalysis Systems.

All interested parties are cordially invited!

The meaning of the physiological state “sleep” has changed massively in the last two decades. Initially, nocturnal sleep was regarded as a passive, resting or conserving state. Today, however, it is known that nocturnal sleep is highly dynamic and influences many life processes during the day, for example cognitive abilities, physical performance processes, but also the risk of disease.

In addition to an overview of the current technical status of clinical sleep medicine, new developments will be presented: contactless and mobile measurement procedures, automated sleep phase classification procedures and also non-clinical applications that are intended to support healthy sleep instrumentally.

Prof. Hagen Malberg is the Director of the Institute for Biomedical Engineering at the TU Dresden, a member of the Faculty of Electrical Engineering and Information Technology and the Medical Faculty “Carl Gustav Carus”. As a medical technology engineer and somnologist, his scientific interest lies in the development of electrical and information technology procedures in the field of medical measurement technology and biosignal analysis as well as automation technology. In addition to sleep and cardiovascular medicine, areas of application are intensive care and transplant medicine as well as rehabilitation technology.

Vibrational spectroscopies – and especially infrared spectroscopy – play an increasingly important role in modern biodiagnostics. This has led to the evolution of mid-infrared photonics from an emerging tool in the clinical/medical domain to an enabling technology. With applications ranging from non-invasive exhaled breath analysis to in-vivo assessment of cartilage damage, mid-infrared (MIR; 3-20 μm) photonics ranges among the most flexible molecular sensing platforms nowadays available. In particular, with the emergence of quantum and interband cascade laser.

technology, the on-chip hybridization and/or integration of entire MIR sensing devices is on the horizon ultimately leading to IR-lab-on-chip systems. The inherent molecular selectivity of MIR signatures enables studying small molecules (e.g., volatile organic compounds; VOCs) in the gas phase, as well as biomacromolecules (e.g., proteins) in the liquid phase at unprecedented detail in a label-free and non-destructive fashion. Last but not least, the combination with advanced multivariate data evaluation and deep learning algorithms facilitates analyses in real-world complex mixtures of biomedical and clinical relevance. The discussion of latest MIR photonic technologies in this presentation we will be augmented by highlight applications underlining the utility of next-generation MIR photonics.

Dr. Boris Mizaikoff is a Chaired Professor and Director of the Institute of Analytical and Bioanalytical Chemistry @ Ulm University, Germany. Since 2021, he is also a Director at the Hahn-Schickard Institute for Microanalysis Systems in Ulm. His research interests focus on optical sensors, biosensors, and biomimetic sensors in the mid-infrared spectral range, system miniaturization and integration based on micro- and nanofabrication, multifunctional (nano)analytical platforms, development of biomolecular/biomimetic recognition architectures, multivariate data evaluation, and applications in environmental analytics, process analysis, and biomedical/clinical diagnostics. He is author/co-author of 400+ peer-reviewed publications, 18 patents, and 100+ plenary, keynote, and invited contributions at scientific conferences.